Expression of multiple granzymes by cytotoxic t lymphocyte implies that they activate diverse apoptotic pathways in target cells

International Reviews of Immunology

Volumn 29, Issue 1, 2010, Pages 38-55

  Zhou, Fang ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Caspase; Cytotoxic T lymphocytes; Granzyme; Natural killer cells; Perforin

Indexed keywords

CASPASE; CYTOCHROME C; GRANZYME; GRANZYME A; GRANZYME B; GRANZYME C; GRANZYME K; GRANZYME M; PERFORIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; ENZYME RELEASE; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; APOPTOSIS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PERFORIN; RATS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 76149132334     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830180903247889     Document Type: Review

References (113)

1. N Sasi, M Hwang, J Jaboin, et al. Regulated cell death pathways: New twists in modulation of BCL2 family function. Mol Cancer Ther 2009;8:1421-1429.
2. YP Ow, DR Green, Z Hao, and TW Mak. Cytochrome c: Functions beyond respiration. Nat Rev Mol Cell Biol 2008;9:532-542.
3. GC Brown and V Borutaite. Regulation of apoptosis by the redox state of cytochrome c. Biochim Biophys Acta 2008;1777:877-881.
4. D Kobayashi, S Ahmed, M Ishida, et al. Calcium/calmodulin signaling elicits release of cytochrome c during 2,3,7,8-tetrachlorodibenzo-p-dioxin- induced apoptosis in the human lymphoblastic T-cell line, L-MAT. Toxicology 2009;258:25-32.
5. M Yabuki, K Tsutsui, AA Horton, et al. Caspase activation and cytochrome c release during HL-60 cell apoptosis induced by a nitric oxide donor. Free Radic Res 2000;32:507-514.
6. N Susnow, L Zeng, D Margineantu, and DM Hockenbery. Bcl-2 family proteins as regulators of oxidative stress. Semin Cancer Biol 2009;19:42-49.
7. D Keefe, L Shi, S Feske, S, et al. Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity 2005;23:249-262.
8. RF Rich and WR Green. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells. J Immunol 2002;168:2751-2758.
9. L Zheng, TJ Dengler, MS Kluger, et al. Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL-mediated lysis provided by caspaseresistant Bcl-2 without alterations in growth or activation responses. J Immunol 2000;164:4665-4671.
10. JM Sheil, TD Schell, SE Shepherd, et al. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6-and bm1-derived cytotoxic T lymphocytes: Presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Eur J Immunol 1994;24:2141-2149.
11. M Hayashida, H Kawano, T Nakano, et al. Cell death induction by CTL: Perforin/ granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells. Proc Soc Exp Biol Med 2000;225:143-150.
12. R Konno, T Igarashi, S Okamoto, et al. Apoptosis of human endometriummediated by perforin and granzyme B of NK cells and cytotoxic T lymphocytes. Tohoku J Exp Med 1999;187:149-155.
13. JA Trapani. Granzymes: A family of lymphocyte granule serine proteases. Genome Biol 2001;2:REVIEWS3014.
14. CM Kam, D Hudig, and JC Powers. Granzymes (lymphocyte serine proteases): Characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000;1477:307-323.
15. M Taniguchi, N Tani, T Suemoto, et al. High expression of alternative transcript of granzyme M in the mouse retina. Neurosci Res 1999;34:115-123.
16. TJ Sayers, AD Brooks, JM Ward, et al. The restricted expression of granzyme M in human lymphocytes. J Immunol 2001;166:765-771.
17. D Masson, M Zamai, and J Tschopp. Identification of granzyme A isolated from cytotoxic T-lymphocyte-granules as one of the proteases encoded by CTL-specific genes. FEBS Lett 1986;208:84-88.
18. J Lieberman. The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 2003;3:361-370.
19. EH Spaeny-Dekking, AM Kamp, CJ Froelich, and CE Hack. Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitors. Blood 2000;95:1465-1472.
20. H Nakajima, HL Park, and PA Henkart. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J Exp Med 1995;181:1037-1046.
21. MS Pasternack, KJ Bleier, and TN McInerney. Granzyme A binding to target cell proteins. Granzyme A binds to and cleaves nucleolin in vitro. J Biol Chem 1991;266:14703-14708.
22. PJ Beresford, M Jaju, RS Friedman, et al. A role for heat shock protein 27 in CTL-mediated cell death. J Immunol 1998;161:161-167.
23. LE Sower, GR Klimpel, W Hanna, and CJ Froelich. Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol 1996;171:159-163.
24. CC Hermsen, Y Konijnenberg, L Mulder, et al. Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin Exp Immunol 2003;132:467-472.
25. LE Sower, CJ Froelich, N Allegretto, et al. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J Immunol 1996;156:2585-2590.
26. HS Suidan, J Bouvier, E Schaerer, et al. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc Natl Acad Sci U S A 1994;91:8112-8116.
27. GBrunner,MMSimon, andMDKramer. Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1. FEBS Lett 1990;260:141-144.
28. D Martinvalet, DM Dykxhoorn, R Ferrini, and J Lieberman. Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 2008;133:681-692.
29. Z Fan, PJ Beresford, D Zhang, and J Lieberman. HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A. Mol Cell Biol 2002;22:2810-2820.
30. Z Fan, PJ Beresford, DY Oh, et al. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003;112:659-672. (Pubitemid 36331778)
31. MV Clement, P Haddad, A Soulie, et al. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Res Immunol 1990;141:477-489.
32. CA Dahl, FH Bach,WChan, et al. Isolation of a cDNA clone encoding a novel form of granzyme B from human NK cells and mapping to chromosome 14. Hum Genet 1990;84:465-470.
33. P Haddad, MV Clement, O Bernard, et al. Structural organization of the hCTLA-1 gene encoding human granzyme B. Gene 1990;87:265-271.
34. M Poe, JT Blake, DA Boulton, et al. Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. J Biol Chem 1991;266:98-103.
35. J Rotonda,MGarcia-Calvo, HG Bull, et al. The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1. Chem Biol 2001;8:357-368.
36. E Estebanez-Perpina, P Fuenter-Prior, D Belorgey, et al. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue. Biol Chem 2000;381:1203-1214.
37. SW Ruggles, RJ Fletterick, and CS Craik. Characterization of structural determinants of granzyme B reveals potent mediators of extended substrate specificity. J Biol Chem 2004;279:30751-30759.
38. J Sun, JC Whisstock, P Harriott, et al. Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop. J Biol Chem 2001;276:15177-15184.
39. SM Waugh, JL Harris, R Fletterick, and CS Craik. The structure of the proapoptotic protease granzyme B reveals the molecular determinants of its specificity. Nat Struct Biol 2000;7:762-765.
40. JL Harris, EP Peterson, D Hudig, et al. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem 1998;273:27364-27373.
41. F Andrade, S Roy, D Nicholson, et al. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis. Immunity 1998;8:451-460.
42. DA Thomas, C Du,MXu, et al. DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity 2000;12:621-632.
43. R Nathaniel, AL MacNeill, YX Wang, et al. Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J Gen Virol 2004;85:1267-1278.
44. A Sarin,MSWilliams,MA Alexander-Miller, et al. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 1997;6:209-215.
45. UB Matter-Reissmann, P Forte, MK Schneider, et al. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression. Xenotransplantation 2002;9:325-337.
46. TW Kelley, B Pohlman, P Elson, and ED Hsi, The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol 2007;128:958-965.
47. C Renvoize, R Roger, N Moulian, et al. Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokineactivated killer cell granule-mediated apoptosis. J Immunol 1997;159:126-134.
48. E Estella, MD McKenzie, T Catterall, et al. Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid. Diabetes 2006;55:2212-2219.
49. NJ Waterhouse, KA Sedelies, and JA Trapani. Role of Bid-induced mitochondrial outer membrane permeabilization in granzyme B-induced apoptosis. Immunol Cell Biol 2006;84:72-78.
50. JB Alimonti, L Shi, PK Baijal, and AH Greenberg. Granzyme B induces BIDmediated cytochrome c release and mitochondrial permeability transition. J Biol Chem 2001;276:6974-6982.
51. JA Heibein, IS Goping,MBarry, et al. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med 2000;192:1391-1402.
52. GV Chaitanya and PP Babu. Multiple apoptogenic proteins are involved in the nuclear translocation of Apoptosis Inducing factor during transient focal cerebral ischemia in rat. Brain Res 2008;1246:178-190.
53. B Nachmias, S Mizrahi,M Elmalech, et al. Manipulation of NK cytotoxicity by the IAP family member Livin. Eur J Immunol 2007;37:3467-3476.
54. DA Thomas, L Scorrano, GV Putcha, et al. Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK. Proc Natl Acad Sci U S A 2001;98:14985-14990.
55. NJWaterhouse, KA Sedelies, KA Browne, et al. A central role for Bid in granzyme B-induced apoptosis. J Biol Chem 2005;280:4476-4482.
56. EOApostolov, XWang, SV Shah, andAGBasnakian. Role of EndoG in development and cell injury. Cell Death Differ 2007;14:1971-1974.
57. D Arnoult, B Gaume,MKarbowski, et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003;22:4385-4399.
58. PJ Duriez and GM Shah. Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death. Biochem Cell Biol 1997;75:337-349.
59. LA Casciola-Rosen, AF Pluta, PH Plotz, et al. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum 2001;44:389-396.
60. T Yamamoto, K Yoneda, E Ueta, et al. Enhanced apoptosis of squamous cell carcinoma cells by interleukin-2-activated cytotoxic lymphocytes combined with radiation and anticancer drugs. Eur J Cancer 2000;36:2007-2017.
61. JJ Pink, SWuerzberger-Davis, C Tagliarino, et al. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis. Exp Cell Res 2000;255:144-155.
62. K Veugelers, B Motyka, C Frantz, et al. The granzyme B-serglycin complex from cytotoxic granules requires dynamin for endocytosis. Blood 2004;103:3845-3853.
63. SM Raja, B Wang, M Dantuluri, et al. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem 2002;277:49523-49530.
64. SS Metkar, B Wang, M Aguilar-Santelises, et al. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 2002;16:417-428.
65. K Veugelers, B Motyka, IS Goping, et al. Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate. Mol Biol Cell 2006;17:623-633.
66. PJ Peters, J Borst, VOorschot, et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 1991;173:1099-1109.
67. GM Griffiths and S Isaaz. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J Cell Biol 1993;120:885-896.
68. JV Reddy, AS Burguete, K Sridevi, et al. A functional role for the GCC185 golgin in mannose 6-phosphate receptor recycling. Mol Biol Cell 2006;17:4353-4363.
69. B Motyka, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 2000;103:491-500.
70. R Dressel, K von Figura, and E Gunther. Unimpaired allorejection of cells deficient for the mannose 6-phosphate receptors Mpr300 andMpr46. Transplantation 2004;78:758-761.
71. JA Trapani, VR Sutton, KY Thia, et al. A clathrin/dynamin-and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death. J Cell Biol 2003;160:223-233.
72. EB Yang, LL Qin, YN Zhao, et al. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virusassociated hepatocellular carcinoma. Int J Mol Med 2003;11:773-778.
73. Y Oka, RA Waterland, JK Killian, et al. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology 2002;35:1153-1163.
74. DE Sleat and P Lobel. Ligand binding specificities of the twomannose 6-phosphate receptors. J Biol Chem 1997;272:731-738.
75. JX Kang, J Bell, RL Beard, and RA Chandraratna. Mannose 6-phosphate/insulinlike growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ 1999;10:591-600.
76. JE Davis, MJ Smyth, and JA Trapani. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity. Eur J Immunol 2001;31:39-47.
77. PJ Beresford, Z Xia, AH Greenberg, and J Lieberman. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity 1999;10:585-594.
78. AJ Zajac, JM Dye, and DG Quinn. Control of lymphocytic choriomeningitis virus infection in granzyme B deficient mice. Virology 2003;305:1-9.
79. A Mullbacher, K Ebnet, RV Blanden, et al. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc Natl Acad Sci U S A 1996;93:5783-5787.
80. RA Pereira,MMSimon, and A Simmons. Granzyme A, a noncytolytic component of CD8(+) cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice. J Virol 2000;74:1029-1032.
81. J Pardo, S Balkow, A Anel, and MM Simon. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells. Eur J Immunol 2002;32:1980-1985.
82. DMartinvalet, P Zhu, and J Lieberman. GranzymeAinduces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005;22:355-370.
83. D Zhang, MS Pasternack, PJ Beresford, et al. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A. J Biol Chem 2001;276:3683-3690.
84. D Zhang, PJ Beresford, AH Greenberg, and J Lieberman. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc Natl Acad Sci U S A 2001;98:5746-5751.
85. J Lieberman and Z Fan. Nuclear war: The granzyme A-bomb. Curr Opin Immunol 2003;15:553-559.
86. KA Browne, RW Johnstone, DA Jans, and JA Trapani. Filamin (280-kDa actinbinding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis. J Biol Chem 2000;275:39262-39266.
87. SC Lee, J Chan, MV Clement, and S Pervaiz. Functional proteomics of resveratrolinduced colon cancer cell apoptosis: Caspase-6-mediated cleavage of lamin A is a major signaling loop. Proteomics 2006;6:2386-2394.
88. S Ruchaud, N Korfali, P Villa, et al. Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J 2002;21:1967-1977.
89. MV Swamy, I Cooma, BS Reddy, and CV Rao. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: A novel approach in developing effective chemopreventive regimens. Int J Oncol 2002;20:753-759.
90. EJ Blink, JA Trapani, and DA Jans. Perforin-dependent nuclear targeting of granzymes: A central role in the nuclear events of granule-exocytosis- mediated apoptosis? Immunol Cell Biol 1999;77:206-215.
91. JA Trapani, P Jans, MJ Smyth, et al. Perforin-dependent nuclear entry of granzyme B precedes apoptosis, and is not a consequence of nuclear membrane dysfunction. Cell Death Differ 1998;5:488-496.
92. D. Chowdhury and J Lieberman. Death by a thousand cuts: Granzyme pathways of programmed cell death. Annu Rev Immunol 2008;26:389-420.
93. JA Trapani and MJ Smyth. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002;2:735-747.
94. HJohnson, L Scorrano, SJKorsmeyer, and TJ Ley. Cell death induced by granzyme C. Blood 2003;101:3093-3101.
95. D Jenne, C Rey, D Masson, et al. cDNA cloning of granzyme C, a granuleassociated serine protease of cytolytic T lymphocytes. J Immunol 1988;140:318-323.
96. NC Bailey and CJ Kelly. Nephritogenic T cells use granzyme C as a cytotoxic mediator. Eur J Immunol 1997;27:2302-2309.
97. K Kawashima, H Doi, Y Ito, et al. Evaluation of cell death and proliferation in psoriatic epidermis. J Dermatol Sci 2004;35:207-214.
98. S Shresta, P Goda, R Wesselschmidt, and TJ Ley. Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytes. J Biol Chem 1997;272:20236-20244.
99. T Zhao, H Zhang, Y Guo, and Z Fan. Granzyme K directly processes bid to release cytochrome c and endonuclease G leading to mitochondria-dependent cell death. J Biol Chem 2007;282:12104-12111.
100. T Zhao, H Zhang, Y Guo, et al. Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death Differ 2007;14:489-499.
101. L Krenacs, MJ Smyth, E Bagdi, et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood 2003;101:3590-3593.
102. K Ebnet, M Hausmann, F Lehmann-Grube, et al. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J 1995;14:4230-4239.
103. JM Kelly, NJ Waterhouse, E Cretney, et al. Granzyme M mediates a novel form of perforin-dependent cell death. J Biol Chem 2004;279:22236-22242.
104. K Bratke, A Klug, P Julius, et al. Granzyme K: A novel mediator in acute airway inflammation. Thorax 2008;63:1006-1011.
105. SS Metkar, C Menaa, J Pardo, et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 2008;29:720-733.
106. J Pardo, R Wallich, K Ebnet, et al. Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. Cell Death Differ 2007;14:1768-1779.
107. WJ Kim, H Kim, K Suk, and WH Lee. Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis. Immunol Lett 2007;111:57-65.
108. C Wagner, S Stegmaier, and GM Hansch. Expression of granzyme B in peripheral blood polymorphonuclear neutrophils (PMN), myeloid cell lines and in PMN derived from haemotopoietic stem cells in vitro. Mol Immunol 2008;45:1761-1766.
109. S Saito, K Murakoshi, S Kotake, et al. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis. J Rheumatol 2008;35:1932-1943.
110. L Gahring, NG Carlson, EL Meyer, and SW Rogers. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J Immunol 2001;166:1433-1438.
111. T Wang, R Allie, K Conant, et al. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J 2006;20:1209-1211.
112. Y Maekawa, Y Minato, C Ishifune, et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat Immunol 2008;9:1140-1147.
113. OO Yang, H Lin,MDagarag, et al. Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytes. Virology 2005;332:16-19.